B7-33 Peptide Vial
Stackpure provides B7-33 Peptide Vial for cardiac fibrosis, heart failure modelling, and vascular biology research. This research-grade peptide vial is a truncated form of H2 relaxin that selectively activates RXFP1 receptors, exhibiting anti-fibrotic, vasodilatory, and cardioprotective properties in pre-clinical cardiovascular models. Produced to +99% purity (HPLC verified), cGMP-certified, with a Certificate of Analysis available every batch.
For in vitro research use only. Not for human consumption. Not approved by the FDA. Not a drug, medicine, or supplement.
Your batch's actual Certificate of Analysis is available on request with your order and batch number, usually within 24 hours. Full testing standards on the Lab Testing page.
B7-33 Peptide Vial is a research-grade peptide vial supplied by Stackpure for laboratory investigation. B7-33 is studied in the context of tissue repair, wound healing, and musculoskeletal recovery. Each unit is manufactured in a cGMP-certified facility and verified to +99% purity by HPLC analysis before dispatch.
What Is B7-33?
B7-33 is a compound that has attracted significant interest in preclinical research examining tissue repair, wound healing, and musculoskeletal recovery. Scientists investigating B7-33 have worked to characterise its mechanisms, receptor interactions, and downstream biological effects across multiple in vitro and animal model systems.
Stackpure provides B7-33 Peptide Vial for researchers requiring verified, traceable material. Supplied as a lyophilised powder vial, this format offers maximum stability and flexibility for laboratory reconstitution. Researchers may also be interested in B7-33 Nasal Spray, which provides the same compound in an alternative format.
this peptide vial Research Applications
Preclinical studies involving this peptide vial have explored the following areas:
- Tissue regeneration: Studies have examined the role of this compound in accelerating repair of damaged connective tissue, tendons, and ligaments.
- Wound healing: Preclinical models have investigated angiogenic and fibroblast-stimulating properties relevant to dermal and mucosal wound repair.
- Musculoskeletal support: Research has explored protective and regenerative effects on muscle, bone, and cartilage under injury conditions.
These directions reflect the broad scientific interest in B7-33 and the growing body of literature examining its potential applications in research contexts.
Stackpure's peptide vial Quality Standards
Every this peptide vial supplied by Stackpure is held to rigorous analytical standards. Researchers choosing Stackpure peptide vial receive material that has been independently verified for identity, purity, and potency. Quality documentation includes a Certificate of Analysis (COA) for every production batch, providing full analytical transparency.
- Purity: +99% by HPLC analysis
- Facility: cGMP-certified manufacturing
- Testing: Identity, purity, and potency verified per batch
- Documentation: COA available for every order
This analytical rigour ensures that researchers working with Stackpure's peptide vial can maintain experimental consistency and reproducibility across studies.
Research Use Disclaimer
Independent Lab Verification
Stackpure works with independent, accredited third-party laboratories, including Vanguard Laboratory (ISO 17025:2017-accredited, A2LA Certificate #6377.01.01), to verify compound identity and purity. A Certificate of Analysis is included with every order.
this peptide vial from Stackpure is supplied strictly for in vitro research and laboratory purposes. This material is not approved for human or veterinary use and is not intended to diagnose, treat, cure, or prevent any condition. All research involving this peptide vial must be conducted in accordance with applicable institutional, ethical, and regulatory guidelines. For research use only.
Working with the lyophilized vial
- Supplied as a freeze-dried powder, which keeps the compound stable until it is needed.
- Requires reconstitution with a suitable diluent such as bacteriostatic water before use in a protocol.
- Unopened vials are kept cold and away from light. Once reconstituted, solutions are kept refrigerated and used within the window set by your protocol.
- Reconstituted concentration depends on the diluent volume you choose, so the same vial supports different working concentrations.
Research Questions
What is B7-33 Peptide Vial used for in research?
this peptide vial is a research-grade peptide vial studied for cardiac fibrosis, heart failure modelling, and vascular biology research. It acts as a truncated form of H2 relaxin that selectively activates RXFP1 receptors, exhibiting anti-fibrotic, vasodilatory, and cardioprotective properties in pre-clinical cardiovascular models. All findings are from pre-clinical in vitro and animal studies; it is not approved for human use.
How does B7-33 Peptide Vial work?
this peptide vial is a truncated form of H2 relaxin that selectively activates RXFP1 receptors, exhibiting anti-fibrotic, vasodilatory, and cardioprotective properties in pre-clinical cardiovascular models. This mechanism has been characterised in multiple pre-clinical studies, with particular focus on cardiac fibrosis outcomes.
What research dosage is used for B7-33 Peptide Vial?
Pre-clinical studies have used 0.5–2 mg/kg/day infusion protocols in rodent heart failure models. All dosage information is from pre-clinical or research contexts only. this peptide vial is sold exclusively for research use and is not approved for human consumption.
How does B7-33 Peptide Vial compare to related research compounds?
this peptide vial is frequently studied alongside Relaxin-2 and serelaxin for cardiovascular peptide research. Its relaxin receptor agonist classification distinguishes its mechanism from these alternatives, making it suitable for pathway-specific research protocols.
Where can I buy B7-33 Peptide Vial for research purposes?
Stackpure supplies this peptide vial as a research-grade peptide vial with +99% purity (HPLC verified), cGMP certification, and a Certificate of Analysis. Orders ship to the US, UK, Canada, and Australia. It is sold for in vitro research use only.
What does the Certificate of Analysis verify for B7-33 Peptide Vial?
A Certificate of Analysis (COA) reports identity (confirming the compound is what it's labeled as, via HPLC-UV/VIS matched against a reference standard) and assay/content (the measured purity percentage). this peptide vial is tested through independent third-party laboratory analysis, including work performed by Vanguard Laboratory (ISO 17025:2017-accredited, A2LA Certificate #6377.01.01), which is what verifies a batch matches its labeled specification rather than relying on a purity claim alone.